Regulation & policy

Behind the scenes tour: From ingredients to the shelf

Behind the scenes tour: From ingredients to the shelf

By Danielle Masterson

A recent tour through several facilities in Tempe, Arizona, offered a behind-the-scenes look at the dietary supplement industry. From raw ingredient sourcing and testing to formulation, manufacturing and finished products, what ultimately reaches store...

NutraCast: How Nutrify C-Suite SumFlex is redefining industry events

NutraCast: How Nutrify C-Suite SumFlex is redefining industry events

By Danielle Masterson

As India’s nutraceutical sector continues to accelerate onto the global stage, the upcoming Nutrify C-Suite SumFlex Summit in Mumbai is positioning itself less as a traditional conference and more as a high-level working boardroom for industry leaders.

Canada update: Red tape reduction in the natural health products sector

Guest column

Canada update: Red tape reduction in the natural health products sector

By Sonia Parmar, Vice President, Government Relations & Regulatory Affairs, Canadian Health Food Association

Canada’s natural health products (NHP) sector, referred to as dietary supplements in the United States, continues to face a persistent gap between policy intent and operational reality.

Health Canada publishes prebiotics monograph

Health Canada publishes prebiotics monograph

By Stephen Daniells

Health Canada’s Natural and Non-prescription Health Products Directorate (NNHPD) has published a monograph for prebiotics, establishing a clear set of rules and the basis for health claims in Canada.

Timeline: Is CBD heading towards a frozen market in the UK?

Timeline: Is CBD heading towards a frozen market in the UK?

By Nikki Hancocks

Recently published minutes from a closed Food Standards Agency board meeting indicate that CBD approvals will be delayed further and are unlikely to occur before the end of summer 2026, raising questions as to whether this could effectively freeze the...

Dietary Supplement Listing Bill introduced in the House

Dietary Supplement Listing Bill introduced in the House

By Stephen Daniells

A first-term member of Congress has introduced the Dietary Supplement Listing Act of 2026 in the U.S. House of Representatives to require dietary supplement manufacturers to list their products with the Food and Drug Administration (FDA).

Supplements 101: Biotic regulations in the European Union

Supplements 101: Biotic regulations in the European Union

By Lauren Nicolle

Biotics are one of the fastest growing categories within the dietary supplement industry, but strict regulations within the European Union often prevent supplement companies from effectively communicating their benefits.

NAD flags Bayer One A Day men’s fertility positioning

NAD flags Bayer One A Day men’s fertility positioning

By Cassandra Stern

The National Advertising Division (NAD) has recommended that Bayer HealthCare LLC discontinue or modify a series of claims tied to its One A Day Men’s Pre-Conception Health Complete Multivitamin, concluding that product positioning and messaging conveyed...

Menopause claims back under the spotlight following ASA review

Menopause claims back under the spotlight following ASA review

By Olivia Haslam

Women’s health brands Lunera, Minerva Wellness and Nova breached multiple advertising codes by making claims that their supplements could treat or significantly alleviate menopause symptoms, according to the UK’s Advertising Standards Authority (ASA).

Is FDA opening the long‑shut DSHEA ‘innovation door’?

Is FDA opening the long‑shut DSHEA ‘innovation door’?

By Stephen Daniells

The upcoming public Food and Drug Administration (FDA) meeting exploring the scope of dietary supplement ingredients will revisit one of the most contested and, according to DSHEA’s architects, most misunderstood phrases in the U.S. dietary supplement law.

What the 2026 monacolin ban could mean for nutraceutical players

What the 2026 monacolin ban could mean for nutraceutical players

By Olivia Haslam

The European Union is set to ban monacolins from red yeast rice (RYR), a key ingredient in high cholesterol management, as early as Q3 2026, leaving the nutraceutical sector scrambling to fill the resulting ‘therapeutic gap’.

Zoe fails to overturn ASA ruling on gut supplement ad

Zoe fails to overturn ASA ruling on gut supplement ad

By Olivia Haslam

Professor Tim Spector says the Advertising Standards Authority (ASA) decision to uphold its ruling that Zoe’s Daily30+ supplement advertisement was misleading is a profound failure of logic. 

The growing role of toxicology in dietary supplement safety

The growing role of toxicology in dietary supplement safety

By Danielle Masterson

As regulatory enforcement and consumer awareness around dietary supplements continue to grow, manufacturers are under increasing pressure to demonstrate safety. At NOW Foods, that commitment includes employing a dedicated toxicologist, a role that...